Antigen binding proteins to oncostatin M (OSM)

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10808029
APP PUB NO 20170152312A1
SERIAL NO

15428528

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention concerns antigen binding proteins and fragments thereof which specifically bind Oncostatin M (OSM), particularly human OSM (hOSM) and which inhibit the binding of OSM to the gp130 receptor but does not directly interact with site II residues. The invention also concerns a method of humanizing antibodies. Further disclosed are pharmaceutical compositions, screening and medical treatment methods.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GLAXO GROUP LIMITEDSTEVENAGE SG1 2NY

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bembridge, Gary Peter Stevenage, GB 7 75
Chung, Chun-wa Stevenage, GB 9 49
Feeney, Maria Stevenage, GB 4 5
Ford, Susannah Karen Stevenage, GB 13 37
Kirby, Ian Stevenage, GB 64 723
McAdam, Ruth Stevenage, GB 17 83

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 20, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 20, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00